Philip Jochelson

机构：Jazz Pharmaceuticals (United States)

发表论文 10 篇 · 总被引 461 次 · h-index 7

代表论文

• Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia (2010 · SLEEP · 被引 192)
• Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia (2011 · SLEEP · 被引 129)
• Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes (2015 · Diabetes Care · 被引 57)
• Efficacy and safety of doxepin 6 mg in a model of transient insomnia (2010 · Sleep Medicine · 被引 34)
• Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial (2021 · Movement Disorders · 被引 21)
• Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin (2016 · Diabetes Obesity and Metabolism · 被引 16)